Evidence map›Paper›PMID 1413526›Full record

ArticleVirology1992

Cell receptor-independent infection by a neurotropic murine coronavirus.

T M Gallagher, M J Buchmeier, S Perlman

Open access · greenAbstract read
In one paragraph

Article in Virology, 1992. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 94 citations in OpenAlex.

  1. Article
  2. Patterns of Recombination in Coronaviruses.International journal of molecular sciences · 2025
    Article
  3. Article
  4. Article
  5. The coronavirus recombination pathway.Cell host & microbe · 2023
    Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Coronavirus Spike Protein and Tropism Changes.Advances in virus research · 2016
    Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

T M GallagherDepartment of Neuropharmacology, Scripps Research Institute, La Jolla, California 92037.
M J Buchmeier
S Perlman
Scripps Research Institute · USUniversity of Iowa · US

Funding

VIRAL INDUCED CNS DISEASESP01NS022347 · NINDS · SCRIPPS RESEARCH INSTITUTE · PI BLOOM, FLOYD ELLIOTT · 1986 to 1993
–
VIRAL AND CELLULAR ALTERATIONS DURING INFECTION IN CELL CULTUREP50NS012428 · NINDS · SCRIPPS RESEARCH INSTITUTE · PI OLDSTONE, MICHAEL B · 1985 to 1994
–
PATHOGENESIS OF ANTIBODY-MODULATED JHM DEMYELINATIONR01NS024401 · NINDS · UNIVERSITY OF IOWA · PI PERLMAN, STANLEY · 1987 to 1994
–
NINDS NIH HHS NS 12428NINDS NIH HHS NS22347NINDS NIH HHS NS24401
6 · The paper itself

Abstract

The cellular receptors for a coronavirus, mouse hepatitis virus (MHV), have been recently identified as one or more members of the carcinoembryonic antigen (CEA) family. The neurotropic JHM strain of MHV (MHV-JHM) possesses a highly fusogenic surface (S) glycoprotein. This protein is now shown to promote the spread of MHV into cells lacking the specific CEA-related MHV receptor. Resistant cells are recruited into MHV-induced syncytium with consequent production of progeny virus. Cell-to-cell spread of virus via membrane fusion without the requirement for specific cell surface receptor offers a novel way for virus to spread within infected hosts.

Indexed as

Membrane GlycoproteinsAnimalsCells, CulturedCoronaviridaeCricetinaeGiant CellsHumansMiceRabbitsReceptors, VirusSpike Glycoprotein, CoronavirusViral Envelope ProteinsVirus ReplicationMembrane GlycoproteinsReceptors, VirusSpike Glycoprotein, CoronavirusViral Envelope Proteins

Identifiers

PMID1413526
PMCPMC7131763
OpenAlexW1978934535

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.